Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:16 PM
Ignite Modification Date: 2025-12-25 @ 2:53 PM
NCT ID: NCT01689350
Description: None
Frequency Threshold: 3
Time Frame: One month for all the adverse events reporting.
Study: NCT01689350
Study Brief: A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Experimental Group Cyclophosphamide (CPA) medication was according to the genotypes of SLE patients. None None 6 47 8 47 View
Control Group Cyclophosphamide (CPA) medication was according to the traditional experiences. None None 19 45 16 45 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Leucopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 10.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.0 View